GC LabCell and Feldan Therapeutics announce license agreement to develop next-generation NK cells for immunotherapy using Feldan Shuttle technology0 Comments
SEOUL, South Korea and QUÉBEC CITY, June 27, 2018 /CNW Telbec/ – GC LabCell (hereafter “GCLC”) and Feldan Therapeutics (hereafter “Feldan”) announced an agreement... Read More →
GC Pharma to Establish Curevo – a Seattle-based New Company Dedicated to Development of New Vaccines0 Comments
YONGIN, South Korea, May 20, 2018 /PRNewswire/ — GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical... Read More →
A Major Project in Canada
GC Mogam Inc.